Norfloxacin D8

Intended high-performance liquid chromatography procedure for the quantification of norfloxacin and its potential impurities in active pharmaceutical ingredient and tablet dosage forms
Bikshal Babu Kasimala1, Useni Reddy Mallu2,Venkateswara Rao Anna1, L. Maheshwara Reddy
Thai Journal of Pharmaceutical Sciences 2018, 42 (1): 27-36
 
HPTLC method for Simultaneous Determination of Norfloxacin and Tinidazole in presence of Tinidazole Impurity
Ibrahim A Naguib, Eglal A Abdelaleem, Eman S Hassan, Nouruddin W Ali
Journal of Chromatographic Science, Volume 57, Issue 1, January 2019, Pages 81–86
 
Validation of reverse phase-hplc method for the quantitative estimation of norfloxacin in pure and pharmaceutical formulation
Babu Giriya Gowda1 , Doddamani Hanumanthanaik
International journal of advanced research in science and engineering Vol.No.6, Issue No.04, April 2017

Norfloxacin D8 is chemically 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-1,4-dihydroquinoline-3-carboxylic acid. Norfloxacin D8 is supplied with detailed characterization data compliant with regulatory guideline. Norfloxacin D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Norfloxacin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.